RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      IL-33/ST2 axis mediates hyperplasia of intrarenal urothelium in obstructive renal injury

      한글로보기

      https://www.riss.kr/link?id=A106057495

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      The monolayered intrarenal urothelium covers the renal papilla and ureteropelvic junction (UPJ). In response to increased renal pressure during obstruction or ischemic injuries, intrarenal urothelial cells begin to proliferate and form a multilayered ...

      The monolayered intrarenal urothelium covers the renal papilla and ureteropelvic junction (UPJ). In response to increased renal pressure during obstruction or ischemic injuries, intrarenal urothelial cells begin to proliferate and form a multilayered urothelium. Little is known regarding the mechanism and pathophysiological role of urothelium hyperplasia during renal obstruction. In this study, we investigated the expression of interleukin (IL)-33, an IL-1 family cytokine, in kidneys with unilateral ureteral obstruction (UUO)-induced obstructive injury. IL-33 levels in hydronephrotic urine and serum were upregulated 2 days after UUO. The number of ST2-expressing immune cells was increased in the UUO kidney. We found that IL-33 was upregulated in vimentin-positive cells in the cortical and medullar layers and the UPJ stroma. Moreover, IL-33 expression was predominantly induced in multilayered keratin 5- positive urothelial cells in the UPJ. IL-33 was not detected in terminally differentiated superficial umbrella cells expressing uroplakin 3a. In vivo, we confirmed that deficiency of IL33 or its receptor ST2 attenuated UUO-induced hyperplasia of the UPJ urothelium. Deficiency of IL33 attenuated the expression of UUO-induced type 2 inflammatory cytokines and upregulated uroplakins and urothelial differentiation signaling in UPJ tissues. Our results collectively suggest that the IL-33/ST2 axis mediates the activation of innate immune responses and contributes to urothelial hyperplasia by regulating urothelial differentiation in obstructive kidney injury.

      더보기

      참고문헌 (Reference)

      1 David J. DeGraff, "When urothelial differentiation pathways go wrong: Implications for bladder cancer development and progression" Elsevier BV 31 (31): 802-811, 2013

      2 Alexey Girshovich, "Ureteral obstruction promotes proliferation and differentiation of the renal urothelium into a bladder-like phenotype" Elsevier BV 82 (82): 428-435, 2012

      3 Robert L. Chevalier, "Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy" Elsevier BV 75 (75): 1145-1152, 2009

      4 Wei-Yu Chen, "Upregulation of Interleukin-33 in obstructive renal injury" Elsevier BV 473 (473): 1026-1032, 2016

      5 Kazunari Sugita, "Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients" Elsevier BV 141 (141): 300-310.e11, 2018

      6 Levent Demirtas, "The possible role of interleukin-33 as a new player in the pathogenesis of contrast-induced nephropathy in diabetic rats" Informa UK Limited 38 (38): 952-960, 2016

      7 Marjorie De la Fuente, "The IL-33/ST2 axis: Role in health and disease" Elsevier BV 26 (26): 615-623, 2015

      8 Antoine Thierry, "The Alarmin Concept Applied to Human Renal Transplantation: Evidence for a Differential Implication of HMGB1 and IL-33" Public Library of Science (PLoS) 9 (9): e88742-, 2014

      9 B. D. Abbott, "TCDD-Induced hyperplasia of the ureteral epithelium produces hydronephrosis in murine fetuses" Wiley 35 (35): 329-334, 1987

      10 Caporali, A., "Soluble ST2 is regulated by p75 neurotrophin receptor and predicts mortality in diabetic patients with critical limb ischemia" 32 : e149-e160, 2012

      1 David J. DeGraff, "When urothelial differentiation pathways go wrong: Implications for bladder cancer development and progression" Elsevier BV 31 (31): 802-811, 2013

      2 Alexey Girshovich, "Ureteral obstruction promotes proliferation and differentiation of the renal urothelium into a bladder-like phenotype" Elsevier BV 82 (82): 428-435, 2012

      3 Robert L. Chevalier, "Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy" Elsevier BV 75 (75): 1145-1152, 2009

      4 Wei-Yu Chen, "Upregulation of Interleukin-33 in obstructive renal injury" Elsevier BV 473 (473): 1026-1032, 2016

      5 Kazunari Sugita, "Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients" Elsevier BV 141 (141): 300-310.e11, 2018

      6 Levent Demirtas, "The possible role of interleukin-33 as a new player in the pathogenesis of contrast-induced nephropathy in diabetic rats" Informa UK Limited 38 (38): 952-960, 2016

      7 Marjorie De la Fuente, "The IL-33/ST2 axis: Role in health and disease" Elsevier BV 26 (26): 615-623, 2015

      8 Antoine Thierry, "The Alarmin Concept Applied to Human Renal Transplantation: Evidence for a Differential Implication of HMGB1 and IL-33" Public Library of Science (PLoS) 9 (9): e88742-, 2014

      9 B. D. Abbott, "TCDD-Induced hyperplasia of the ureteral epithelium produces hydronephrosis in murine fetuses" Wiley 35 (35): 329-334, 1987

      10 Caporali, A., "Soluble ST2 is regulated by p75 neurotrophin receptor and predicts mortality in diabetic patients with critical limb ischemia" 32 : e149-e160, 2012

      11 Zarine R. Balsara, "Sleeping beauty: awakening urothelium from its slumber" American Physiological Society 312 (312): F732-F743, 2017

      12 Saulo Klahr, "Obstructive nephropathy and renal fibrosis" American Physiological Society 283 (283): F861-F875, 2002

      13 Karl S. Roth, "Obstructive Uropathy: An Important Cause of Chronic Renal Failure in Children" SAGE Publications 41 (41): 309-314, 2016

      14 Wei-Yu Chen, "Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33" Proceedings of the National Academy of Sciences 112 (112): 7249-7254, 2015

      15 Onk, D., "Melatonin attenuates contrast-induced nephropathy in diabetic rats: the role of interleukin-33 and oxidative stress" 2016 : 9050828-, 2016

      16 David J. DeGraff, "Loss of the Urothelial Differentiation Marker FOXA1 Is Associated with High Grade, Late Stage Bladder Cancer and Increased Tumor Proliferation" Public Library of Science (PLoS) 7 (7): e36669-, 2012

      17 Sedat Caner, "Is IL-33 useful to detect early stage of renal failure?" Informa UK Limited 36 (36): 78-80, 2013

      18 Yuan-Yow Chiou, "Intrinsic expression of Th2 cytokines in urothelium of congenital ureteropelvic junction obstruction" Elsevier BV 67 (67): 638-646, 2005

      19 C. Vinsonneau, "Intrarenal urothelium proliferation: an unexpected early event following ischemic injury" American Physiological Society 299 (299): F479-F486, 2010

      20 Clare Hardman, "Interleukin-33, friend and foe in type-2 immune responses" Elsevier BV 42 : 16-24, 2016

      21 Nikolas T Martin, "Interleukin 33 is a guardian of barriers and a local alarmin" Springer Nature 17 (17): 122-131, 2016

      22 Hye Young Kim, "Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity" Elsevier BV 129 (129): 216-227.e6, 2012

      23 Laurel A Monticelli, "Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus" Springer Nature 12 (12): 1045-1054, 2011

      24 Ya-Jen Chang, "Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity" Springer Nature 12 (12): 631-638, 2011

      25 Jan-Hendrik Riedel, "IL-33–Mediated Expansion of Type 2 Innate Lymphoid Cells Protects from Progressive Glomerulosclerosis" American Society of Nephrology (ASN) 28 (28): 2068-2080, 2017

      26 Gregory D. Rak, "IL-33-Dependent Group 2 Innate Lymphoid Cells Promote Cutaneous Wound Healing" Elsevier BV 136 (136): 487-496, 2016

      27 Thomas R. Shelite, "IL-33-Dependent Endothelial Activation Contributes to Apoptosis and Renal Injury in Orientia tsutsugamushi-Infected Mice" Public Library of Science (PLoS) 10 (10): e0004467-, 2016

      28 Ryba-Stanislawowska, M, "IL-33 effect on quantitative changes of CD4+CD25highFOXP3+ regulatory T cells in children with type 1 diabetes" 2016 : 9429760-, 2016

      29 FEIFEI YANG, "IL-33 and kidney disease (Review)" Spandidos Publications 13 (13): 3-8, 2016

      30 Ali Akcay, "IL-33 Exacerbates Acute Kidney Injury" American Society of Nephrology (ASN) 22 (22): 2057-2067, 2011

      31 Vuvi G. Tran, "IL-33 Enhances Host Tolerance to Candida albicans Kidney Infections through Induction of IL-13 Production by CD4 + T Cells" The American Association of Immunologists 194 (194): 4871-4879, 2015

      32 Deepti R. Nagarkar, "IL-13 mediates IL-33–dependent mast cell and type 2 innate lymphoid cell effects on bronchial epithelial cells" Elsevier BV 136 (136): 202-205, 2015

      33 Kunyoo Shin, "Hedgehog Signaling Restrains Bladder Cancer Progression by Eliciting Stromal Production of Urothelial Differentiation Factors" Elsevier BV 26 (26): 521-533, 2014

      34 Tammer Yamany, "Formation and regeneration of the urothelium" Ovid Technologies (Wolters Kluwer Health) 19 (19): 323-330, 2014

      35 Michael S. Forbes, "Fight-or-flight: murine unilateral ureteral obstruction causes extensive proximal tubular degeneration, collecting duct dilatation, and minimal fibrosis" American Physiological Society 303 (303): F120-F129, 2012

      36 P. Baumgart, "Epithelial Abnormalities in the Renal Pelvis in Experimental Hydronephrosis and Pyelonephritis" Elsevier BV 176 (176): 185-195, 1983

      37 Chen, W. Y, "Emerging roles of IL-33/ST2 axis in renal diseases" 18 : 2017

      38 Bruhs, A, "Disruption of the epidermal barrier induces regulatory T cells via IL-33 in mice" 16 : 2017

      39 Hiroyuki Iwahana, "Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells" Wiley 264 (264): 397-406, 1999

      40 K. Yasuda, "Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice" Proceedings of the National Academy of Sciences 109 (109): 3451-3456, 2012

      41 Yu-Shi Bao, "Characterization of Interleukin-33 and Soluble ST2 in Serum and Their Association with Disease Severity in Patients with Chronic Kidney Disease" Springer Nature 32 (32): 587-594, 2012

      42 Andrew P. Evan, "Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats" Elsevier BV 65 (65): 154-161, 2004

      43 Yen-Rei A. Yu, "A Protocol for the Comprehensive Flow Cytometric Analysis of Immune Cells in Normal and Inflamed Murine Non-Lymphoid Tissues" Public Library of Science (PLoS) 11 (11): e0150606-, 2016

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2009-09-21 학회명변경 한글명 : 대한생화학ㆍ분자생물학회 -> 생화학분자생물학회
      영문명 : Korean Society Of Medical Biochemistry And Molecular Biology -> Korean Society Of Biochemistry And Molecular Biology
      KCI등재
      2008-01-01 평가 SCI 등재 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2001-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1998-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 3.74 0.23 2.56
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      1.82 1.45 0.555 0.01
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼